Transcription Start Site Mapping Using Super-low Input Carrier-CAGE
June 26th, 2019
13.4K views
Cap Analysis of Gene Expression (CAGE) is a method for genome-wide quantitative mapping of mRNA 5’ends to capture RNA polymerase II transcription start sites at a single-nucleotide resolution. This work describes a low-input (SLIC-CAGE) protocol for generation of high-quality libraries using nanogram-amounts of total RNA.
Overview
Cap Analysis of Gene Expression (CAGE) is a technique for mapping mRNA 5’ ends to identify transcription start sites with single-nucleotide resolution. This article presents the SLIC-CAGE protocol, which allows for high-quality library generation from low amounts of total RNA.
Key Study Components
Area of Science
- Gene regulation
- Transcriptional analysis
- RNA sequencing
Background
- CAGE enables the discovery of core promoters and enhancers.
- It is effective with minimal starting material, using only 10 nanograms of RNA.
- The technique is valuable for identifying disease-associated transcription start sites.
- SLIC-CAGE is suitable for analyzing frail cell types and embryonic tissues.
Purpose of Study
- To provide a low-input protocol for high-resolution promoter analysis.
- To extend CAGE applications to small sample sizes like tissue biopsies.
- To improve the identification of transcription start sites in various organisms.
Methods Used
- Preparation of PCR mix and reverse transcription of RNA.
- Purification of products using SPRI magnetic beads.
- qPCR for library amplification and size selection.
- Comparison of SLIC-CAGE performance with NanoCAGE.
Main Results
- SLIC-CAGE produces sequencing-ready libraries from nanogram amounts of RNA.
- The final library fragment length ranges from 200 to 2,000 base pairs.
- It shows improved performance in transcription start site identification compared to NanoCAGE.
- Careful handling minimizes sample loss, ensuring high-quality libraries.
Conclusions
- SLIC-CAGE enables detailed promoter analysis in previously inaccessible cell types.
- The protocol is crucial for studying early embryonic development.
- It enhances the understanding of gene regulation in various model organisms.
Frequently Asked Questions
What is the main advantage of SLIC-CAGE?
SLIC-CAGE allows for unbiased, genome-wide mapping of transcription start sites using low amounts of RNA.
How much RNA is required for SLIC-CAGE?
Only 10 nanograms of total RNA is needed to perform the SLIC-CAGE protocol.
What types of samples can SLIC-CAGE be applied to?
It is suitable for small samples such as tissue biopsies and frail cell types.
How does SLIC-CAGE compare to NanoCAGE?
SLIC-CAGE exhibits significantly better performance in identifying transcription start sites than NanoCAGE.
What is the fragment length of the final library?
The final library fragment length ranges between 200 and 2,000 base pairs.
Why is minimizing sample loss important?
Minimizing sample loss is crucial to avoid low-complexity libraries and ensure high-quality sequencing results.
Executive Industry Relevance
Accurate transcription start site mapping enables precise identification of core promoters and enhancers, which is critical for target validation in early drug discovery. SLIC-CAGE extends this capability to low-input samples such as tissue biopsies and rare cell types, expanding the range of biologically relevant systems accessible for mechanistic de-risking. This supports predictive confidence in target selection by linking transcriptional regulation to disease-associated genomic elements.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of transcriptional hypotheses through genome-wide promoter and enhancer mapping at single-nucleotide resolution.
- Operational Value: Reduces biological ambiguity by linking regulatory elements to gene expression in disease-relevant systems.
- Scientific Value: Supports functional target validation by identifying disease-associated transcription start sites as potential biomarkers or mechanistic anchors.
Screening & Assay Development
- Scientific Value: Generates quantitative, reproducible TSS data suitable for assay standardization in promoter-focused screening campaigns.
- Operational Value: Enables library preparation from nanogram RNA inputs, allowing scalable screening of limited or precious biological samples.
- Scientific Value: Produces sequencing-ready libraries with defined fragment length distribution (200–2,000 bp), reducing artifacts and improving data reliability for downstream analytics.
Translational & Preclinical Research
- Scientific Value: Facilitates translational biomarker discovery by mapping active enhancers and promoters in frail cell types and embryonic tissues.
- Operational Value: Provides continuity from discovery to preclinical validation by enabling consistent TSS profiling across model systems and developmental stages.
- Scientific Value: Supports risk-adjusted advancement decisions by correlating transcriptional dynamics with phenotypic outcomes in preclinical models.
Pipeline & Workflow Integration
SLIC-CAGE fits within the early discovery continuum, supporting target identification through mechanistic insight into gene regulation before progressing to lead identification and preclinical validation.
- Discovery Biology: Enables hypothesis testing and pathway clarification by mapping transcriptional initiation events across the genome.
- Screening: Delivers assay-ready, quantitative TSS measurements that support reproducible compound screening in low-input formats.
- Analytics: Provides high-resolution, single-nucleotide TSS data and fragment length profiles that allow precise comparison of transcriptional states across conditions.
- Translational Research: Connects to preclinical work by enabling promoter and enhancer analysis in disease-relevant tissues and developmental models.
- Enterprise Reuse: Establishes a reusable, standardized method for transcriptional profiling that can be applied across projects and model systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing uncertainty in promoter and enhancer annotation.
- Operational Value: Enhances reproducibility and scalability through carrier-based normalization and minimal input requirements.
- Strategic Value: Improves go/no-go decisions by enabling early detection of regulatory risks associated with target modulation.
- Portfolio Impact: Supports risk-adjusted prioritization by linking transcriptional activity to disease mechanisms and biomarker potential.
Implementation Considerations
- Requires expertise in molecular biology, RNA handling, and next-generation sequencing library preparation.
- Dependent on access to thermocyclers, magnetic stands, SPRI beads, and qPCR instrumentation for library quantification.
- Necessitates standardized protocols across teams to ensure carrier consistency and minimize batch effects in TSS detection.
- Must account for variations in RNA integrity and input quality when adapting to diverse model systems or clinical samples.
- Practical limitation: Multi-day protocol duration requires careful scheduling and skilled personnel to prevent sample loss during transfers.
Biopharma FAQs
Why does single-nucleotide TSS resolution matter for target validation?
Single-nucleotide resolution enables precise mapping of core promoters and enhancers, which is essential for linking transcriptional regulation to disease mechanisms and validating targets at the genomic level.
How does carrier-based RNA amplification support low-input workflows in discovery?
The SLIC-CAGE carrier increases effective RNA input without introducing bias, allowing library preparation from as little as 10 ng of total RNA, thus enabling analysis of scarce samples like biopsies.
What quantitative TSS measurements enable comparative analysis across conditions?
SLIC-CAGE produces genome-wide, quantitative TSS tags that allow precise comparison of promoter usage and enhancer activity between experimental groups, supporting mechanistic de-risking.
Why are replication and sample consistency critical in TSS mapping for cross-functional teams?
Replication ensures reliable detection of true transcriptional start sites by minimizing technical noise and sample loss, which is essential for generating consistent, interpretable data across biology and computational teams.
What analytical capabilities are needed to interpret SLIC-CAGE data for target prioritization?
Bioinformatics pipelines capable of processing CAGE-seq data to identify TSSs, quantify promoter activity, and detect bidirectional enhancer signatures are required to translate raw data into actionable target insights.
Chapters in this video
0:04
Title
1:04
Preparation of DNA Templates
1:38
Reverse Transcription
2:24
Purification of cDNA:RNA Hybrids Using Magnetic Beads
3:42
Cap-trapping
5:16
Control of Degradation Level and Determination of the Number of PCR Cycles
5:39
Results: DNA Quality and Validation of SLIC-CAGE Libraries
6:26
Conclusion
